[Detection of residual disease in follicular lymphomas using the PCR technique: importance of clono-specific probes].
Follicular lymphoma constitutes 30-40% of non-Hodgkin's lymphomas. Most patients have widespread disease at diagnosis. The clinical course is generally indolent, and it is not usually curable with available treatment. The source of relapse in patients who achieve complete clinical remission is residual neoplastic cells that are present below the limits of detection using standard techniques. With the development of PCR technology, the presence of these residual malignant cells [Minimal Residual Disease (MRD)] has been demonstrated clearly. Recently, an association of high-dose chemotherapy with autologous bone marrow or peripheral blood progenitor cell autograft appeared promising in the treatment of these lymphomas. In the search of clonal markers for the detection of MRD in follicular lymphomas, two strategies can be used. In the cases associated with the t(14;18) (q32;q21) chromosomal translocation, the bcl-2/JH junctional regions are amplified by PCR in approximately equal to 50% of cases and then sequenced in order to synthesize an anti-junction oligonucleotide probe specific for each patient's malignant clone (clonospecific probe). In the cases negative for this translocation, an alternative strategy consists in the amplification of immunoglobulin high chain (IgH) gene rearrangement (approximately equal to 75% of cases). The present review highlights the value of molecular markers such as bcl-2/JH and VH/JH rearrangements to follow the neoplastic clone and to detect MRD in patients with follicular lymphomas.
al Saati
T
T
Laboratoire d'anatomie pathologique et UPCM/CNRS, CHU-Purpan, Toulouse, France.
Galoin
S
S
Roda
D
D
Huynh
A
A
Attal
M
M
Delsol
G
G
D002883:Chromosomes, Human, Pair 14; D002887:Chromosomes, Human, Pair 18; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain / Q000235:genetics; D005819:Genetic Markers; D006801:Humans; D008224:Lymphoma, Follicular / Q000175:diagnosis* / Q000235:genetics; D018365:Neoplasm, Residual; D015345:Oligonucleotide Probes; D016133:Polymerase Chain Reaction / Q000379:methods; D014178:Translocation, Genetic / Q000235:genetics*
D005819:Genetic Markers; D015345:Oligonucleotide Probes
Détection de la maladie résiduelle dans les lymphomes folliculaires par la technique de PCR: intérêt des sondes clono-spécifiques.